Novartis Awaits Invite To Bid On Aventis, Says Combination Is "Viable"

Novartis wants a formal invitation from the Aventis board and a "neutral position" by the French government before it enters into merger negotiations. Novartis believes there is a "business case" for the merger, which it envisions as a two-step transaction including a spin-off of "non-core" products.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet